Search

Your search keyword '"17-Hydroxycorticosteroids urine"' showing total 2,915 results

Search Constraints

Start Over You searched for: Descriptor "17-Hydroxycorticosteroids urine" Remove constraint Descriptor: "17-Hydroxycorticosteroids urine"
2,915 results on '"17-Hydroxycorticosteroids urine"'

Search Results

1. Musculoskeletal disorders, psychosocial stress and associated factors among home-based migrant care workers.

2. Comparing older and younger Japanese primiparae: fatigue, depression and biomarkers of stress.

3. Ketoacidosis and adrenocortical insufficiency.

4. Cancer-related fatigue and chemotherapy-associated adverse effects: correlation with TNF-α, IL-1 and 17-hydroxycorticosteroids.

5. Reaction of the adrenal cortex to graded exercise in children with different initial tonus of the autonomic nervous system.

6. [11-Hydroxycorticoid, 17-hydroxycorticoid].

8. 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.

9. Daily profiles of salivary and urinary melatonin and steroids in healthy prepubertal boys.

10. Xenobiotic action on steroid hormone synthesis and sulfonation the example of lead and polychlorinated biphenyls.

11. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.

12. Neuroendocrine system response modulates oxidative cellular damage in burn patients.

13. Stress barometer at diagnoses in children with school non-attendance.

14. [Partial Addison's disease].

15. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.

16. Difficulty in the diagnosis of Cushing disease.

17. [17-Hydroxycorticoid (17-OHCS)].

18. [Urinary 17-ketogenic steroids (17-KGS) and 17-KGS fractions].

19. Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction.

20. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.

21. Impact of amphotericin B on the cytochrome P450 system in HIV-infected patients.

22. Relationship between fluvoxamine and stress barometer for nocturnal enuresis.

23. Virilising adrenocortical tumours in children.

24. Adrenal insufficiency due to isolated adrenocorticotropin deficiency complicated by autosomal recessive polycystic kidney disease.

25. [A study of logotherapy for chronic low back pain patients].

26. [A study of psychoneuroendocrinological effects of music therapy].

27. [Determination of 17-hydroxycorticosteroid by capillary zone electrophoresis].

28. A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome.

29. Effect of exercise training on serum leptin levels in type 2 diabetic patients.

30. Urinary 17-hydroxycorticosteroids and 17-ketosteroid sulfates in normal children and in children with atopic dermatitis or renal disease.

31. Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome.

32. Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome.

33. Interference by danazol with the Porter-Silber method for determination of urinary 17-hydroxycorticosteroids.

34. [Cushing syndrome--a pathologic analysis based on 216 resected specimens].

35. A case of renin-producing adrenocortical cancer.

36. Salt-induced exacerbation of morning surge in blood pressure in patients with essential hypertension.

39. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease.

40. [Determination of cortisol in plasma and 24-hour urine of patients with central serous chorioretinopathy].

41. Increased sensitivity to thyroid hormone replacement therapy followed by hyponatremia and eosinophilia in a patient with long-standing young-onset primary hypothyroidism.

43. Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up.

44. [Significance of measuring urinary 17-ketosteroid sulfates at the work-place].

45. [17-KS sulfate as a biomarker in psychosocial stress].

46. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations.

47. [17-ketosteroid sulfates and its application to kampo-medicine].

48. [Comprehensive medicine and 17-KS-S].

49. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.

50. Cushing's syndrome due to unilateral adrenocortical hyperplasia.

Catalog

Books, media, physical & digital resources